Episode Thumbnail
Episode 35  |  31:53 min

How Phagenesis Is Using Regulatory Affairs as They Develop a Treatment for Dysphagia

Episode 35  |  31:53 min  |  11.07.2019

How Phagenesis Is Using Regulatory Affairs as They Develop a Treatment for Dysphagia

00:00
00:00
This is a podcast episode titled, How Phagenesis Is Using Regulatory Affairs as They Develop a Treatment for Dysphagia. The summary for this episode is: How Phagenesis Is Using Regulatory Affairs as They Develop a Treatment for Dysphagia with Rebecca Sheridan What if regulatory affairs were not only viewed as a necessary burden, but actually help a medical device company? Our guest today thinks that is exactly the case. Phagenesis, a greenlight.guru customer, is a new type of medical device startup company with a fascinating story. Their products are transforming the lives of people with dysphagia by restoring neurological control of swallowing. Nestlé recently struck a deal to acquire Phagenesis as reported by The WSJ. Today Jon is talking with Rebecca Sheridan, Head of Quality Assurance and Regulatory Affairs at Phagenesis. Join us as Rebecca shares more about her background, the Phagenesis story and the role of regulatory affairs in the medical device industry. Some of the topics discussed today include: ● Rebecca’s professional background ● Differences between large and small medical device companies and joining Phagenesis ● Involving the whole team in regulatory affairs to make it work for everyone ● Using greenlight.guru as a tool at Phagenesis ● Advice for medical device startups ● Overview of Phagenesis and dysphagia treatments
How Phagenesis Is Using Regulatory Affairs as They Develop a Treatment for Dysphagia with Rebecca Sheridan What if regulatory affairs were not only viewed as a necessary burden, but actually help a medical device company? Our guest today thinks that is exactly the case. Phagenesis, a greenlight.guru customer, is a new type of medical device startup company with a fascinating story. Their products are transforming the lives of people with dysphagia by restoring neurological control of swallowing. Nestlé recently struck a deal to acquire Phagenesis as reported by The WSJ. Today Jon is talking with Rebecca Sheridan, Head of Quality Assurance and Regulatory Affairs at Phagenesis. Join us as Rebecca shares more about her background, the Phagenesis story and the role of regulatory affairs in the medical device industry. Some of the topics discussed today include: ● Rebecca’s professional background ● Differences between large and small medical device companies and joining Phagenesis ● Involving the whole team in regulatory affairs to make it work for everyone ● Using greenlight.guru as a tool at Phagenesis ● Advice for medical device startups ● Overview of Phagenesis and dysphagia treatments

More Episodes

Understanding and Handling Different Types of Feedback

Measuring the Impact of AI/ML Technologies on the Current Medical Device Landscape

Post-Pandemic Readiness: Preparing for the Aftermath of COVID-19 on the Medical Device Industry

Tips to Prepare for EU MDR and IVDR as Deadlines Draw Near

How will Emergency Use Authorization (EUA) during Pandemic Influence Future FDA Policy Changes?

Why SaMD Companies Should be Leveraging Pre-Submissions to FDA